Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01921140
Recruitment Status : Active, not recruiting
First Posted : August 13, 2013
Last Update Posted : June 21, 2021
Sponsor:
Information provided by (Responsible Party):
AstraZeneca